It is now almost difficult to imagine back to a time before COVID-19 turned the world upside
down. The pandemic has taken an enormous toll on patients, families and communities …

We read with great interest the recent article by Caricchio et al reporting preliminary
predictive criteria for COVID-19 cytokine storm (COVID-CS). 1 Early risk stratification for …

We thank Prof Ferraccioli for his positive comments on our open-label trials with sarilumab,
tocilizumab, anakinra and mavrilimumab in patients with severe hyperinflamed COVID-19 1 …

We value Dr. Caricchio's and Dr. Criner's appreciation of our commentary on the role of
rheumatologists in the coronavirus disease 2019 (COVID-19) pandemic1. We applaud …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can
lead to clinical expression of the coronavirus disease (COVID-19). COVID-19 itself has a …

As a rheumatology community, we looked on the new decade with excitement and ambition
yet now instead find ourselves amidst the most significant global public healthcare …

It is abundantly clear that a subset of patients admitted to hospital with COVID-19 develop
hyper inflammatory complications of severe COVID-19 infec tion or cytokine storm …

The COVID-19 pandemic shattered our world, whether at home or in our professional lives.
Many of our colleagues or us were in the frontlines. Family and friends turned ill. Meanwhile …

After its emergence in December 2019 in Wuhan, China, the COVID-19 outbreak has now
one of its main epicentres in Lombardy (Italy), with more than 50 000 confirmed cases and …

Diseases includes the freshly minted European Alliance of Associations for Rheumatology
(EULAR) points to consider on the pathophysiology and use of immunomodulatory therapies …